For example, inhibition of FTO expression using FB23 and FB23-2 affects cell cycle and apoptosis in acute myeloid leukemia (AML), which can significantly damage the growth and proliferation of cancer cells, and then achieve the purpose of cancer therapy [268]. The gene discussed is FTO; the disease is cancer.